Navigation Links
Lithium May help in Alzheimer's Disease

Alzheimer's affects about 12 million people worldwide. Lithium may have a potential role in treating Alzheimer's. Lithium targets an enzyme called GSK-3 that facilitates the modification of both the proteins found in Alzheimer's patients. Identification of GSK-3 as a target could help in developing other drugs that disrupt the production of both proteins.

Another advantage to lithium is that it does not disrupt the processing of another protein called notch, as do other potential Alzheimer's drugs. Notch is vital for the production of blood cells.
The drug has been used for decades to treat manic depression. //Alzheimer's is marked by the buildup in the brain of one protein, called amyloid beta, outside nerve cells and a second, called tau, that forms tangles in the cells. Many scientists believe that the accumulation of amyloid beta causes the debilitating effects of the memory-robbing disease.

The recent issue of the journal Nature has reported that in mice experiments, Lithium blocks the production of proteins that form deposits in the brains of Alzheimer's patients. Lithium, though widely used to treat mental problems does have many side effects, including kidney damage.
"Potentially, lithium could be used to reverse both the pathological features of Alzheimer's disease," said Dr. Peter Klein of the University of Pennsylvania who co-authored the current study. "It seems you could block with a single medicine both of the major structural manifestations of the disease. This would be the first time that has been shown," said Dr. Sam Gandy, director of the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia.

Klein and his colleagues overproduce a protein that when modified forms amyloid beta in mice. The mouse experiments showed that lithium disrupts that modification process. They also showed that lithium disrupts the modification of tau. Currently it is unclear what role tau plays i n cellsin the progression of Alzheimer's.

Alzheimer's disease usualy starts at the age of 60 years and involves the parts of the brain that control thought, memory, and language. At present we do not know what causes Alzheimer's and there is no cure.
'"/>




Related medicine news :

1. High Doses of Lithium-Like Drugs May Impair Neuronal Function
2. Lithium Increases Gray Matter in Bipolar Brains
3. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
4. Decrease in testosterone levels lead to Alzheimers
5. Smokers are prone to Alzheimers
6. Over-The-Counter Drugs May Prevent Alzheimers
7. Alzheimers followed by head injury
8. Vitamin E useful for Alzheimers
9. Staying mentally energitic prevents Alzheimers
10. Researchers trick Alzheimers Enzyme
11. Drug Offers Hope for Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 ... brings up a new, often overlooked aspect of head lice: the parasite’s ability to live ... not a common occurrence, but a necessary one in the event that lice have simply ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin ... companies that call for a minimum wage raise to $12 an hour by 2020 and ... This will restore the lost value of the minimum wage, assure the wage floor does ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
Breaking Medicine Technology: